Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
about
Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.
P2860
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@ast
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@en
type
label
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@ast
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@en
prefLabel
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@ast
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@en
P2093
P2860
P921
P1433
P1476
Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.
@en
P2093
Alfonso Quintás-Cardama
Hussein Abbas
Sean M Post
Vinod Pant
P2860
P304
P356
10.18632/ONCOTARGET.100712
P407
P5008
P577
2010-07-01T00:00:00Z